Tests Confirm Pablo Neruda Had Terminal Cancer

The Chilean poet had prostate cancer in an advanced state, with extended metastasis, according to an analysis of his remains

Join Our Community of Science Lovers!

Originally posted on the Nature news blog

At the moment of his death, Chilean poet Pablo Neruda had a prostate cancer in advanced state, with extended metastasis, according to the first analysis of his remains, carried on by the Chilean Legal Medical Service (SML). The results were delivered yesterday to Mario Carroza, the prosecution judge who is investigating the cause of the Nobel Laureate’s death in 1973.

Whether the death was caused by that cancer, or rather by poisoning, as a key witness has claimed, may be cleared by a toxicological analysis that is being carried on in North Carolina.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Neruda’s body was unearthed from his tomb in Isla Negra, Chile, in early April, as part of an investigation opened after Neruda’s former driver Manuel Araya said that the real cause of the poet’s death was an unscheduled injection that he received a few hours before dying.

The first set of analyses included histological and radiological tests. The SML declined to provide more details but the Chilean newspaper El Mercurio said the experts’ team has found “irregular destruction” and osteonecrosis in bone fragments of the dorsal and lumbar vertebrae, features of the bone metastasis that appear in advanced prostate cancer.

This article is reproduced with permission from the magazine Nature and the Nature news blog. The article was first published on May 7, 2013.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe